Computed tomography-ultrasound fusion brachytherapy: Description and evolution of the technique

Brachytherapy

Volumn 6, Issue 4, 2007, Pages 272-279

  Fuller, Donald B ^a   Jin, Haoran ^b  

^a Radiation Medical Group Inc   (United States)

^b Western Cancer Center Inc   (United States)

Author keywords

Adjustment; Computed tomography; CT; CT ultrasound; Dosimetry; Dosimetry feedback; Dynamic brachytherapy; Image fusion; Real time; Ultrasound

Indexed keywords

ARTICLE; BRACHYTHERAPY; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSIMETRY; ECHOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

BRACHYTHERAPY; HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 35649021184     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2007.08.003     Document Type: Article

References (15)

1. Kupelian P.A., Potters L., Khuntia D., et al. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or = 72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys 58 (2004) 25-33
2. Blasko J.C., Grimm P.D., Sylvester J.E., et al. Related articles, Palladium-103 brachytherapy for prostate carcinoma. Int J Radiat Oncol Biol Phys 46 (2000) 839-850
3. Grimm P.D., Blasko J.C., Sylvester J.E., et al. 10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy. Int J Radiat Oncol Biol Phys 51 (2001) 31-40
4. Potters L., Morgenstern C., Calugaru E., et al. 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer. J Urol 173 (2005) 1562-1566
5. Stone N.N., Stock R.G., and Unger P. Intermediate term biochemical-free progression and local control following 125iodine brachytherapy for prostate cancer. J Urol 173 (2005) 803-807
6. Stock R.G., Stone N.N., Dahlal M., et al. What is the optimal dose for 125I prostate implants? A dose-response analysis of biochemical control, posttreatment prostate biopsies, and long-term urinary symptoms. Brachytherapy 1 (2002) 83-89
7. Merrick G.S., Butler W.M., Tollenaar B.G., et al. The dosimetry of prostate brachytherapy-induced urethral strictures. Int J Radiat Oncol Biol Phys 52 (2002) 461-468
8. Crook J.M., Potters L., Stock R.G., et al. Critical organ dosimetry in permanent seed prostate brachytherapy: Defining the organs at risk. Brachytherapy 4 (2005) 186-194
9. Fuller D.B., Jin H., Koziol J.A., et al. CT-ultrasound fusion prostate brachytherapy: A dynamic dosimetry feedback and improvement method. A report of 54 consecutive cases. Brachytherapy 4 (2005) 207-216
10. Holm H.H., Juul N., Pedersen J.F., et al. Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. J Urol 130 (1983) 283-286
11. D'Amico A., Cormack R., Kumar S., et al. Real-time magnetic resonance imaging-guided brachytherapy in the treatment of selected patients with clinically localized prostate cancer. J Endourol 14 (2000) 367-370
12. Stone N.N., and Stock R.G. Brachytherapy for prostate cancer: Real-time three-dimensional interactive seed implantation. Tech Urol 1 (1995) 72-80
13. Potters L., Calguaru E., Thornton K.B., et al. Toward a dynamic real-time intraoperative permanent prostate brachytherapy methodology. Brachytherapy 2 (2003) 172-180
14. Todor D.A., Zaider M., Cohen G.N., et al. Intraoperative dynamic dosimetry for prostate implants. Phys Med Biol 48 (2003) 1153-1171
15. Gong L., Cho P.S., Han B.H., et al. Ultrasonography and fluoroscopic fusion for prostate brachytherapy dosimetry. Int J Radiat Oncol Biol Phys 54 (2002) 1322-1330